NCT02237794

Brief Summary

The purpose of this study is to determine the effect of medical treatment on longitudinal myocardial function. Patients who have been hospitalized for reasons other than heart disease will be examined with Transthoracic Cardiography before and after medical treatment to determine change in myocardial function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 11, 2014

Completed
20 days until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

September 11, 2014

Status Verified

September 1, 2014

Enrollment Period

2 years

First QC Date

September 9, 2014

Last Update Submit

September 9, 2014

Conditions

Heart Function

Outcome Measures

Primary Outcomes (1)

  • Longitudinal Myocardial Function

    Analysis of longitudinal contractility of the heart by the calculation of the heart's strain factor before and after chronic medication treatment.

    Two Years

Study Arms (1)

Patients Without Acute Heart Conditions

Patients without acute heart conditions who were hospitalized for other medical indications.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients hospitalized in an Internal Medicine Department of the Hillel Yaffe Medical Center having a variety of medical conditions and treated with a variety of medications including Beta Blockers, Calcium Channel Blockers, Angiotensine Converting Enzyme Inhibitors and diuretics and do not suffer from overt heart conditions. \--------------------------------------------------------------------------------

You may qualify if:

  • Hospitalized patients receiving above-mentioned medications

You may not qualify if:

  • Patients suffering from heart conditions
  • Patients unable to undergo Echocardiography
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, 38100, Israel

Location

Study Officials

  • David Blondheim, MD

    Hillel Yaffe Medical Center

    STUDY CHAIR

  • Said Younis, MD

    Hillel Yaffe Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Said Younis, MD

CONTACT

972-5-446-66274saidjy@gmail.com

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2014

First Posted

September 11, 2014

Study Start

October 1, 2014

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

September 11, 2014

Record last verified: 2014-09

Locations

IL(1)